Post-COVID-19 syndrome in a sample of climacteric women living in Latin America. Issue 2 (6th February 2023)

• Record Type: Journal Article
• Authors: Blümel, Juan Enrique; Vallejo, María Soledad; Bencosme, Ascanio; Calle, Andrés; Dextre, Maribel; Díaz, Karen; López, Marcela; Miranda, Carlos; Ñañez, Mónica; Ojeda, Eliana; Rey, Claudia; Rodrigues, Marcio Alexandre Hipólito; Salinas, Carlos; Tserotas, Konstantinos; Aedo, Sócrates; Pérez-López, Faustino R.
• Is Part Of: Menopause. Volume 30:Issue 2(2023)
• Page Start: 165
• Page End: 173
• Publication Date: 2023-02-06
• Subjects: COVID-19 -- Fear of COVID-19 Scale -- Jenkins Sleep Scale -- Menopause Rating Scale -- Post-COVID-19 -- Postmenopausal women -- Resilience -- SARS-CoV-2; Menopause -- Periodicals; 618.175005
• DOI: 10.1097/GME.0000000000002123
• Languages: English
• ISSNs: 1072-3714

Abstract

Abstract : A series of physical and psychological symptoms that impair mental health and quality of life can affect a significant percentage of middle-aged and postmenopausal women who have had COVID-19. Current evidence supports implementing interventions to increase resilience along with appropriate clinical management of sleep-related and climacteric complaints. Abstract: Objective: The aim of this study was to assess resilience, fear of COVID-19, sleep disorders, and menopause-related symptoms after the acute phase of COVID-19 in middle-aged women with positive reverse transcription-polymerase chain reaction and noninfected women. Methods: This is a cross-sectional, analytical study of climacteric women from 9 Latin American countries, aged 40-64 years, attending a routine health checkup. We evaluated clinical characteristics and used the Connor-Davidson Resilience Scale, the Fear of COVID-19 Scale, the Jenkins Sleep Scale, and the Menopause Rating Scale to evaluate their health. Results: A total of 1, 238 women were studied, including 304 who were positive for COVID-19 reverse transcription-polymerase chain reaction. The median (interquartile range) age was 53 (12) years; years of studies, 16 (6); body mass index, 25.6 (5.1) kg/m 2 ; and time since first COVID-19 symptom, 8 (6) months. COVID-19 patients reported fatigability (18.8%), joint and muscular discomfort (14.1%), and anosmia (9.5%). They had a significantly lower resilience score (26.87 ± 8.94 vs 29.94 ± 6.65), higher Fear of COVID-19 score (17.55 ± 7.44 vs 15.61 ± 6.34), and a higher Jenkins Scale score (6.10 ± 5.70 vs 5.09 ± 5.32) compared with control women. A logistic regression model confirmed these results. There was not a significant difference in the total Menopause Rating Scale score, although the odds ratios for both severe menopausal symptoms (1.34; 95% confidence interval, 1.02-1.76) and the use of hypnotics were higher in women with COVID-19 (1.80; 95% confidence interval, 1.29-2.50) compared with those without infection. We found no decrease in studied outcomes between the initial 7 months versus those reported after 8 to 18 months since first COVID-19 symptoms. Conclusions: COVID-19 climacteric women have sleep disorders, lower resilience and higher fear of COVID-19.